Researcher profile

Yilong Zhang

Yilong Zhang contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
6works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

6 published item(s)

preprint2026arXiv

First Submillimeter Lights from Dome A: Tracing the Carbon Cycle in the Feedback of Massive Stars

The cycling of carbon between its ionized, atomic, and molecular phases shapes the chemical compositions and physical conditions of the interstellar medium (ISM). However, ground-based studies of the full carbon cycle have been limited by atmospheric absorption. Dome~A, the most promising site for submillimeter astronomy, has long resisted successful submillimeter astronomical observations. Using the 60~cm Antarctic Terahertz Explorer, we present the first successful CO ($4-3$) and [CI] ($^3P_1 - ^3P_0$) mapping observations of two archetypal triggered massive star-formation regions at Dome~A. These data, together with archival [CII], provide the first complete characterization of all three carbon phases in these environments. We find elevated C$^{0}$/CO abundance ratios in high-extinction regions, plausibly driven by deep penetration of intense radiation fields from massive stars into a clumpy ISM. These findings mark a major milestone for submillimeter astronomy at Dome~A and offer valuable insights into the impact of massive star feedback on the surrounding ISM.

preprint2024arXiv

Extension of the Topological Abel-Jacobi Map for Cubic Threefolds

The difference $[L_1]-[L_2]$ of a pair of skew lines on a cubic threefold defines a vanishing cycle on the cubic surface as the hyperplane section spanned by the two lines. By deforming the hyperplane, the flat translation of such vanishing cycle forms a 72-to-1 covering space $T_v$ of a Zariski open subspace of $(\mathbb P^4)^*$. Based on a lemma of Stein on the compactification of finite analytic covers, we found a compactification of $T_v$ to which the topological Abel-Jacobi map extends. Moreover, the boundary points of the compactification can be interpreted in terms of local monodromy and the singularities on cubic surfaces. We prove the associated map on fundamental groups of topological Abel-Jacobi map is surjective.

preprint2023arXiv

Degeneration of Dual Varieties of Hypersurfaces

Consider a one-parameter family of smooth projective varieties X_t which degenerate into a simple normal crossing divisor at t=0. What is the dual variety in the limit? We answer this question for a hypersurface of degree d degenerate to the union of two hypersurfaces of degree d_1 and d-d_1 meeting transversely. We find all the irreducible components of the dual variety in the limit and their multiplicities.

preprint2022arXiv

Impact of impurities on drift wave instabilities in reversed-field pinch plasmas

The drift wave in the presence of impurity ions was investigated numerically in reversed field pinch (RFP) plasmas, using the gyrokinetic integral eigenmode equation. It was found that in RFP plasmas with hollow density profiles, an increase in $k_θρ_s$ increases the growth rate of the ion temperature gradient (ITG). Comparing the results of regular and hollow plasma density profile shows that the ITG mode under the hollow density profile is much harder to be excited. For the impurities' effects, when the impurities' density gradient is opposite to the primary ions, namely when $L_{ez}$ is negative, impurities could enhance the instability. On the contrary, when $L_{ez}$ is positive, the instability is stabilized. Regarding the trapped electron mode (TEMs), the growth rate under the plasma with hollow density profile remained minor than that for the standard density gradient. There exists a threshold of $L_{ez}$. When $L_{ez}$ is less than this value, impurity destabilizes TEMs, while as $L_{ez}$ is greater than this, impurity stabilizes TEMs. The effects of $L_{ez}$ on TEM also depend on both the plasma density gradient and the impurity species. In addition, the influence of collisionality on TEMs was also studied.

preprint2022arXiv

Robust analyses for longitudinal clinical trials with missing and non-normal continuous outcomes

Missing data is unavoidable in longitudinal clinical trials, and outcomes are not always normally distributed. In the presence of outliers or heavy-tailed distributions, the conventional multiple imputation with the mixed model with repeated measures analysis of the average treatment effect (ATE) based on the multivariate normal assumption may produce bias and power loss. Control-based imputation (CBI) is an approach for evaluating the treatment effect under the assumption that participants in both the test and control groups with missing outcome data have a similar outcome profile as those with an identical history in the control group. We develop a general robust framework to handle non-normal outcomes under CBI without imposing any parametric modeling assumptions. Under the proposed framework, sequential weighted robust regressions are applied to protect the constructed imputation model against non-normality in both the covariates and the response variables. Accompanied by the subsequent mean imputation and robust model analysis, the resulting ATE estimator has good theoretical properties in terms of consistency and asymptotic normality. Moreover, our proposed method guarantees the analysis model robustness of the ATE estimation, in the sense that its asymptotic results remain intact even when the analysis model is misspecified. The superiority of the proposed robust method is demonstrated by comprehensive simulation studies and an AIDS clinical trial data application.

preprint2022arXiv

Sensitivity analysis in longitudinal clinical trials via distributional imputation

Missing data is inevitable in longitudinal clinical trials. Conventionally, the missing at random assumption is assumed to handle missingness, which however is unverifiable empirically. Thus, sensitivity analysis is critically important to assess the robustness of the study conclusions against untestable assumptions. Toward this end, regulatory agencies often request using imputation models such as return-to-baseline, control-based, and washout imputation. Multiple imputation is popular in sensitivity analysis; however, it may be inefficient and result in an unsatisfying interval estimation by Rubin's combining rule. We propose distributional imputation (DI) in sensitivity analysis, which imputes each missing value by samples from its target imputation model given the observed data. Drawn on the idea of Monte Carlo integration, the DI estimator solves the mean estimating equations of the imputed dataset. It is fully efficient with theoretical guarantees. Moreover, we propose weighted bootstrap to obtain a consistent variance estimator, taking into account the variabilities due to model parameter estimation and target parameter estimation. The finite-sample performance of DI inference is assessed in the simulation study. We apply the proposed framework to an antidepressant longitudinal clinical trial involving missing data to investigate the robustness of the treatment effect. Our proposed DI approach detects a statistically significant treatment effect in both the primary analysis and sensitivity analysis under certain prespecified sensitivity models in terms of the average treatment effect, the risk difference, and the quantile treatment effect in lower quantiles of the responses, uncovering the benefit of the test drug for curing depression.